74 related articles for article (PubMed ID: 2454306)
1. Cytokeratins in cervical dysplasia and neoplasia: a comparative study of immunohistochemical staining using monoclonal antibodies NCL-5D3, CAM 5.2, and PKK1.
Angus B; Kiberu S; Purvis J; Wilkinson L; Horne CH
J Pathol; 1988 May; 155(1):71-5. PubMed ID: 2454306
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of involucrin in cervical condyloma and intraepithelial neoplasia.
Saito K; Saito A; Fu YS; Cheng L; Hilborne LH
Int J Gynecol Pathol; 1986; 5(4):308-18. PubMed ID: 3542863
[TBL] [Abstract][Full Text] [Related]
3. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia.
Smedts F; Ramaekers F; Robben H; Pruszczynski M; van Muijen G; Lane B; Leigh I; Vooijs P
Am J Pathol; 1990 Mar; 136(3):657-68. PubMed ID: 1690513
[TBL] [Abstract][Full Text] [Related]
4. [The location of keratins 17 and 8 in the metaplastic proliferates of the endocervix].
Bulanova EA; Chipysheva TA; Ermilova VD; Gel'shteĭn VI
Arkh Patol; 1994; 56(5):69-73. PubMed ID: 7535046
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cytokeratin marker CAM 5.2 in cervical neoplasia.
Raju GC
Histopathology; 1988 Apr; 12(4):437-43. PubMed ID: 2453439
[TBL] [Abstract][Full Text] [Related]
6. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.
Vessey CJ; Wilding J; Folarin N; Hirano S; Takeichi M; Soutter P; Stamp GW; Pignatelli M
J Pathol; 1995 Jun; 176(2):151-9. PubMed ID: 7636625
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.
Litvinov SV; van Driel W; van Rhijn CM; Bakker HA; van Krieken H; Fleuren GJ; Warnaar SO
Am J Pathol; 1996 Mar; 148(3):865-75. PubMed ID: 8774141
[TBL] [Abstract][Full Text] [Related]
8. Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix.
Brustmann H; Hager M
Ann Diagn Pathol; 2009 Oct; 13(5):303-7. PubMed ID: 19751906
[TBL] [Abstract][Full Text] [Related]
9. [Expression of the protein marker p16INK4a in the cervix uteri cancer].
Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; Spitkovskiĭ DD
Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694
[TBL] [Abstract][Full Text] [Related]
10. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical study on keratin of squamous cell carcinoma of the uterine cervix].
Nagata J; Okabe K; Negishi Y; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):33-40. PubMed ID: 1371799
[TBL] [Abstract][Full Text] [Related]
12. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.
Smedts F; Ramaekers F; Leube RE; Keijser K; Link M; Vooijs P
Am J Pathol; 1993 Feb; 142(2):403-12. PubMed ID: 7679549
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.
Comerci JT; Runowicz CD; Flanders KC; De Victoria C; Fields AL; Kadish AS; Goldberg GL
Cancer; 1996 Mar; 77(6):1107-14. PubMed ID: 8635131
[TBL] [Abstract][Full Text] [Related]
16. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
17. [Argyrophilic proteins in the nucleolar organizer in the differential diagnosis of cervical dysplasias and cancer].
Diadyk EA; Vasilenko IV; Smirnova EA; Raĭkhlin NT
Arkh Patol; 1993; 55(2):23-7. PubMed ID: 7980057
[TBL] [Abstract][Full Text] [Related]
18. Keratin expression in cervical cancer.
Smedts F; Ramaekers F; Troyanovsky S; Pruszczynski M; Link M; Lane B; Leigh I; Schijf C; Vooijs P
Am J Pathol; 1992 Aug; 141(2):497-511. PubMed ID: 1379783
[TBL] [Abstract][Full Text] [Related]
19. NCL-5D3: a new monoclonal antibody recognizing low molecular weight cytokeratins effective for immunohistochemistry using fixed paraffin-embedded tissue.
Angus B; Purvis J; Stock D; Westley BR; Samson AC; Routledge EG; Carpenter FH; Horne CH
J Pathol; 1987 Dec; 153(4):377-84. PubMed ID: 2448441
[TBL] [Abstract][Full Text] [Related]
20. LA-1 oncogene. A possible new prognostic index for evaluating cervical squamous intraepithelial lesions.
Sainz de la Cuesta R; Reed TP; Brothman JC; Dubin NH
J Reprod Med; 1993 Mar; 38(3):173-8. PubMed ID: 8487232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
